Types of Research Peptides — A Complete Category Overview (2026)
Why Categorizing Peptides Matters
There are now hundreds of peptide compounds under active research, and trying to understand them one at a time without any organizing framework makes the field feel far more fragmented than it actually is. Once you group peptides by the biological system they primarily act on, the landscape becomes much easier to navigate, and so does understanding which compound is relevant to a given research question.
This guide breaks research peptides into the five categories that the field has largely settled into, growth hormone peptides, tissue repair and healing peptides, metabolic peptides, cognitive and neurological peptides, and mitochondrial peptides, and explains what distinguishes each group at the mechanistic level. For background on peptides as a class before diving into categories, see our guide on what are research peptides.
Browse the full catalog organized by these categories in our Research Compounds catalog.
Growth Hormone Peptides
This category includes compounds that act on the growth hormone axis, the hypothalamic pituitary system responsible for pulsatile GH secretion. Two distinct mechanisms operate within this single category, and understanding the difference matters more than treating all GH peptides as interchangeable.
GHRH analogs activate the growth hormone releasing hormone receptor on pituitary somatotrophs, working through a cAMP dependent pathway. Sermorelin and CJC-1295 fall into this group, differing mainly in how resistant they are to enzymatic breakdown and therefore how long their effect persists. GHRPs, or growth hormone releasing peptides, work through an entirely separate receptor, the ghrelin receptor GHS-R1a, triggering a calcium dependent signaling cascade. Ipamorelin is the most selective compound in this group, producing GH release without the appetite or cortisol effects seen with older GHRPs.
The two mechanisms are often studied together precisely because they are independent, combining a GHRH analog with a GHRP produces a synergistic GH release that exceeds either pathway alone. Patriot Peptides carries Sermorelin, CJC-1295 DAC, and Ipamorelin for this category of research.
Tissue Repair and Healing Peptides
This category covers peptides studied for wound healing, tendon and ligament repair, and tissue regeneration, and it is one of the most extensively published areas in the entire peptide research field.
BPC-157 works primarily through VEGFR2 mediated angiogenesis and nitric oxide signaling, concentrating its activity locally at an injury site. TB-500, a fragment of Thymosin Beta-4, works through actin regulation, promoting systemic migration of repair competent cells toward injury sites from anywhere in the body. The two are frequently studied in combination precisely because one works locally and the other works systemically, addressing different dimensions of the same repair process. GHK-Cu, a naturally occurring copper binding tripeptide, belongs in this category as well, with published research describing effects on over 4,000 human genes related to collagen synthesis and extracellular matrix remodeling.
Patriot Peptides carries BPC-157, TB-500, and GHK-Cu individually, and the combination of BPC-157 and TB-500 alongside PEG-MGF in Trinity Plus.
Metabolic Peptides
Metabolic peptides have become the largest single category by search volume and research interest, driven primarily by the GLP-1 receptor agonist class. This category includes compounds that act on appetite signaling, insulin secretion, and glucose homeostasis through gut hormone receptor pathways.
Retatrutide represents the most advanced compound currently in research, a triple receptor agonist activating GLP-1, GIP, and glucagon receptors simultaneously, distinguishing it from dual agonists like Tirzepatide which activate only two of those three receptors. The glucagon receptor component in particular drives additional energy expenditure effects that GLP-1 only or dual agonist compounds do not produce.
Patriot Peptides carries Retatrutide for metabolic pathway research. For a detailed comparison of receptor mechanisms across this drug class, see our guide on Retatrutide vs Tirzepatide.
Cognitive and Neurological Peptides
This category includes peptides studied for neurotransmitter modulation, neuroprotection, and effects on cognitive function, with much of the foundational research originating from work in Russian clinical settings before expanding internationally.
Semax, a synthetic ACTH fragment, is studied for BDNF upregulation and has documented research interest in stroke recovery and cognitive enhancement contexts. Selank, a tuftsin analog, is studied for its modulation of GABA, serotonin, and dopamine pathways, with research interest centered on anxiolytic mechanisms that do not carry the dependency profile associated with classical anxiolytic drugs.
Patriot Peptides carries N-Acetyl Semax Amidate and N-Acetyl Selank Amidate, both dual modified for extended metabolic stability compared to the unmodified parent peptides.
Mitochondrial Peptides
This is the newest and mechanistically most distinctive category, built around a discovery that reframed how researchers think about mitochondria entirely. Mitochondrial derived peptides are encoded directly within mitochondrial DNA, rather than nuclear DNA, which is the genome responsible for essentially every other peptide and protein in the human body.
MOTS-C, encoded in the mitochondrial 12S rRNA gene, activates AMPK through a folate dependent pathway and is studied as an exercise mimetic compound with documented metabolic regulation effects. Humanin, encoded in a separate mitochondrial gene, works through entirely different cytoprotective and anti apoptotic mechanisms. SS-31, while not itself mitochondrially encoded, belongs in this category functionally, since it works by binding cardiolipin directly on the inner mitochondrial membrane, a completely distinct mechanism from either MOTS-C or Humanin.
Patriot Peptides carries MOTS-C, Humanin, and SS-31, three compounds that approach mitochondrial biology from three structurally distinct angles.
Why the Category Boundaries Sometimes Blur
A handful of compounds resist clean categorization, and this is worth acknowledging rather than forcing every peptide into exactly one box. Tesamorelin, for instance, is mechanistically a GHRH analog, placing it in the growth hormone category, but its primary published clinical application is visceral fat reduction, which is a metabolic outcome. Thymosin Alpha-1 does not fit neatly into any of the five categories above, since its primary mechanism is immune modulation through toll like receptor signaling on dendritic cells, a category of its own that intersects with several others depending on the specific research application.
This is a feature of how peptide biology actually works rather than a flaw in the categorization system. Many peptides have a primary mechanism that places them clearly in one category while producing secondary effects that touch on others, and the categories in this guide should be understood as the dominant research framing for each compound rather than a rigid, mutually exclusive classification.
Frequently Asked Questions
What are the main types of research peptides?
The major categories are growth hormone peptides, which act on the GHRH receptor or the ghrelin receptor to drive GH release, tissue repair and healing peptides studied for wound healing and tendon repair, metabolic peptides centered on the GLP-1 receptor pathway, cognitive and neurological peptides that modulate neurotransmitter systems, and mitochondrial peptides, a newer category built around compounds encoded in or acting on mitochondrial biology directly.
What is the difference between GHRH and GHRP peptides?
GHRH analogs like Sermorelin and CJC-1295 activate the growth hormone releasing hormone receptor through a cAMP dependent pathway. GHRPs like Ipamorelin activate a different receptor, the ghrelin receptor GHS-R1a, through a calcium dependent pathway. The two are mechanistically independent, which is why they are frequently studied together for synergistic GH release.
Why are mitochondrial peptides considered their own category?
Mitochondrial derived peptides like MOTS-C and Humanin are encoded directly within mitochondrial DNA rather than the nuclear DNA responsible for nearly every other peptide and protein in the body. This distinct genetic origin, combined with their unique mechanisms tied to mitochondrial function, sets them apart from peptides that work through conventional cell surface receptor signaling.
Do all peptides fit cleanly into one category?
No. Some compounds, including Tesamorelin and Thymosin Alpha-1, have mechanisms or research applications that span more than one category. Tesamorelin is mechanistically a GHRH analog but is primarily studied for a metabolic outcome, visceral fat reduction. These categories represent the dominant research framing for each compound rather than a strict, mutually exclusive system.
Which category of research peptides is the most studied?
Metabolic peptides, particularly those acting on the GLP-1 receptor pathway, currently represent the largest category by both published research volume and search interest, driven by the rapid clinical development of compounds like Tirzepatide, Semaglutide, and Retatrutide.
All Patriot Peptides products are strictly for laboratory research use only. Not for human consumption, veterinary use, or clinical application.
Related reading: What Are Research Peptides? | Are Research Peptides Legal in the USA? | Research Compounds Catalog